Phase II Study of TKI258 in Advanced Urothelial Carcinoma
Public ClinicalTrials.gov record NCT00790426. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Multi-center, Non-randomized, Open Label Study of TKI258 in FGFR3 Mutated and FGFR3 Wild Type Advanced Urothelial Carcinoma
Study identification
- NCT ID
- NCT00790426
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Interventions
- TKI258 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2010
- Primary completion
- Mar 31, 2012
- Completion
- Mar 31, 2012
- Last update posted
- Dec 18, 2020
2010 – 2012
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego - Moores Cancer Center UCSD | La Jolla | California | 92093-0658 | — |
| USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3 | Los Angeles | California | 90053 | — |
| University Chicago Hospital CTKI258A2201 | Chicago | Illinois | 60637 | — |
| Dana Farber Cancer Institute Dana 1230 | Boston | Massachusetts | 02215 | — |
| Nevada Cancer Institute Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering (2) | New York | New York | 10065 | — |
| Duke University Medical Center Dept.ofDukeUniversityMedCtr(2) | Durham | North Carolina | 27710 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00790426, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2020 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00790426 live on ClinicalTrials.gov.